Thromb Haemost 2007; 97(02): 169-170 DOI: 10.1160/TH07-01-0007
Schattauer GmbH
Retinal vein occlusion disease and platelet activation: Will antiplatelet therapy be a promising therapeutic strategy for patients with retinal vein occlusion disease in the future?
Suzanne Fateh-Moghadam
1
Medizinische Klinik mit Schwerpunkt Kardiologie, Campus Virchow-Klinikum, Charite-Universitätsmedizin, Berlin, Germany
,
Meinrad Gawaz
2
Medizinische Klinik III, Universitätsklinikum Tübingen, Tübingen, Germany
› Author Affiliations
References
1
Shahid H,
Hossain P,
Amoaku WM.
The management of retinal vein occlusion: is interventional ophathalmology the way forward?. Br J Ophtalmol 2006; 90: 627-639.
2
Cheru KC,
Zegans ME.
Ophtalmology Review Manual. Philadelphia, Lippincott Williams & Wilkins,. 2000: 132-146.
3
Prisco D,
Marcucci R.
Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 2002; 32: 308-311.
4
Vannas S,
Tarkkanen A.
Retinal vein occlusion and glaucoma: tonographic study of the incidence of glaucoma and of its prognostic significance. Br J Ophtalmol 1960; 44: 583-589.
5
Janssen MC,
den Heijer M,
Cruysberg JR.
et al. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis?. Thromb Haemost 2005; 93: 1021-1026.
6
Vine AK.
Hyperhomocyteinemia: a risk factor for central retinal vein occlusion. Am J Ophtalmol 2000; 129: 640-644.
7
Leoncini G,
Bruzzese D,
Signorello MG.
et al. Platelet activation by collagen is increased in retinal vein occlusion. Thromb Haemost 2007; 97: 218-227.
8
Watson PG,
Gordon JL,
Kok D.
et al. Platelet aggregation study in ischemic retinal vascular disease. Trans Ophtalmol Soc UK 1971; 91: 223-230.
9
Priluck IA.
Impending central venal occlusion associated with increased platelet aggregability. Ann Ophtalmol 1979; 11: 79-84.
10
Houtsmuller AJ,
Vermeulen JACM,
Klompe M.
et al. The influence of ticlopidine on the natural course of retinal venal occlusion. Agents Actions Suppl 1984; 15: 219-229.
11
Walsh PN,
Goldberg RE,
Tax RL.
et al. Platelet coagulant activities and retinal vein thrombosis. Thromb Haemost 1977; 38: 399-406.
12
Hayreh SS.
Management of central vein occlusion. Ophtalmologica 2003; 217: 167-188.
13
Yamamoto T,
Kamei M,
Yokoi N.
et al. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering. Am J Ophtalmol 2004; 138: 809-817.